GlobalData Plc
  • Press Release

    Non-small cell lung cancer has largest number of clinical trials in Australia and Globally over the last 5 years

A recent analysis of clinical trial activity in Australia by GlobalData, a leading data and analytics company, revealed that 3,199 clinical trials across all diseases and phases took place in the country between January 01, 2012 and December 31, 2016. Non-small cell lung cancer had the largest number of clinical trials overall in Australia, a pattern reflected globally.

A spokesperson from the Healthcare Analyst team at GlobalData commented, ‘‘The largest number of global clinical trials overall took place in non-small cell lung cancer, with 122 trials, followed by type 2 diabetes, hepatitis C, solid tumour, and breast cancer.’’

Phase II was the most frequent phase globally, ranging from 26–48% of trials for each indication. Phase III was the second most frequent phase, making up 54% of hepatitis C trials. Phase I made up the highest percentage in solid tumour trials.

Related Intelligence

Want more Insight like this?

Our interactive subscription platform has the most comprehensive data and analysis in your industry.

Request a Demo

Related Consulting

How can we help your business?

Our consultants are skilled in every specialist market niche to deliver solutions specifically designed for your individual requirements.

Request a Callback

Media Enquiries

If you are a member of the press or media and require any further information, please get in touch, as we’re very happy to help.

Emailpr@globaldata.com
PhoneEMEA: +44 207 832 4399
PhoneAPAC: +91 40 6616 6809
Onlinecontact online

56% of #consumers are concerned about the impact of diet. Join us for more insight @incosmetics #cosmetics #trends… https://t.co/wJOJOqYIJF